A recent review of biomarkers that determine prognosis in CML also presented a list of prognostic indicators at diagnosis, such as the three scoring systems, BCR-ABL1 transcript type, and OA [135]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.